×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
LS03: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model?DCT & Remote Utilization (Part 1)
Session Chair(s)
Hiroshi Matsuzawa, MSc
Clinical Development
Astellas Pharma Inc., Japan
Toshihiro Sano, RPh
Associate Vice President, Head of Clinical Operations
Merck Sharp & Dohme LLC , United States
Speaker(s)
Ai Nakamura
R&D Head Club, Japan
Performance Working Group Member
Takeshi Hashimoto, MPharm
Novartis Pharma K.K., Japan
Co-leader
Masahito Yamanaka
EFPIA (Bayer Yakuhin, Ltd.), Japan
Taskforce Member
Junichi Tanokashira
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Clinical Evaluation Expert Committee, Drug Evaluation Committee